Press Releases
 
JCB to Test Multipurpose Biometric Authentication

For potential launch of authentication and payment scheme using visible light palm authentication

TOKYO, 5 January 2018 -- (ACN Newswire) -- JCB Co., Ltd., announced that JCB will be running a trial of multipurpose server-based visible light palm authentication in February at JCB headquarters in Tokyo, Japan, in collaboration with Universal Robot Co., Ltd. (UR), and the National Institute of Advanced Industrial Science and Technology.

Image 1: https://www.acnnewswire.com/topimg/jcb_palm_1.jpg

The trial will use UR's visible light palm authentication, using both palm print and vein patterns, which has the world's highest level of accuracy at only 1 in 100 billion false acceptance rate (see note below). The trial will focus on testing technical aspects during the registration and payment flow: capturing customer palm print and vein patterns with a smartphone camera, storing the patterns on a server, performing authentication, and returning the results to the smartphone.

JCB will be studying how to utilize the authentication technology for a wide variety of services while only requiring the customer to register their palm information in the authentication server once using their own smartphone.

About visible light palm authentication:

In contrast to the palm vein technology using near-infrared light currently in general use, Universal Robot has made it possible to capture vein patterns with visible light for authentication purposes. This means that authentication can be done with just a smartphone camera. In addition, the technology is highly accurate, with only a 0.0003% possibility of misidentification. Universal Robot has patented the technology in Japan, the USA, and other countries.

The visible light palm authentication used in this trial actually combines palm vein pattern authentication with palm print search of the data base to find the person's information. This technology boasts the world's highest level of accuracy due to the combination of palm vein pattern and palm print identification.

Note: "1 in 100 billion false acceptance rate" is calculated from 0.0003% rate for palm vein pattern authentication and 0.0003% for palm print authentication.

Image 2: https://www.acnnewswire.com/topimg/jcb_palm_2.jpg

About JCB

JCB is a major global payment brand and a leading payment card issuer and acquirer in Japan. JCB launched its card business in Japan in 1961 and began expanding worldwide in 1981. As part of its international growth strategy, JCB has formed alliances with hundreds of leading banks and financial institutions globally to increase merchant coverage and card member base. As a comprehensive payment solution provider, JCB commits to provide responsive and high-quality service and products to all customers worldwide. For more information, please visit: http://www.global.jcb/en/

Contact:
Kumiko Kida
JCB Co., Ltd.
Corporate Communications
Tel: +81-3-5778-8353
Email:

# # #


Submitted by ACN Newswire, ACN Newswire on Friday, 5 January 2018 at 10:00 AM
Category: Enterprise Technology
 
Related News

Increase Ranking & Discover Niche Keywords For Your Products & Services With The Research & Marketin
Monday, 22 Jan 2018

Suprema to Showcase Biometric-based Centralized Access Control at Intersec 2018
Friday, 19 Jan 2018

Global Mixed Signal System-on-Chip (MxSoC) Market is Expected to Reach USD 765.1 Billion by 2022
Friday, 19 Jan 2018

Rip DVD to 300+ Formats with the Most Powerful DVD Ripper Offered by TuneFab
Friday, 19 Jan 2018

TEPCO looks to the transformative potential of blockchain by investing in Electron
Friday, 19 Jan 2018

Related Events

Palo Alto Networks: Cyber Threat Workshop
Wednesday, 24 Jan 2018

Palo Alto Networks: Netherlands Epic Cloud Security Dinner
Tuesday, 6 Feb 2018

V National Show & Forum for the Civil Aviation Infrastructure
Wednesday, 7 Feb 2018

Tire Technology Expo 2018 - Hannover, Germany - 20-22 February
Tuesday, 20 Feb 2018

Palo Alto Networks: Live Demo: Preventing Security Breaches on the Endpoint
Wednesday, 21 Feb 2018

Latest News

Mexico Wind Power Market Outlook to 2030: Ken Research
Tuesday, 23 Jan 2018

Hemp Seeds Market Drivers & Restraints, Region-wise Outlook and Key Players 2025
Tuesday, 23 Jan 2018

Many Guild Wars 2 Players Have Begun To Use GW2 Sale As Their Premier In-Game Item Store
Tuesday, 23 Jan 2018

Residential Air Purifier Market Size, Share, Growth, Analysis and Forecast 2017 To 2025: Credence Re
Tuesday, 23 Jan 2018

24 Hour Emergency Service Covering Uk, Scotland, Ireland And Wales Announced!
Tuesday, 23 Jan 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 23 January 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Mayo Clinic Cardiology Update at Cabo: A Focus on Prevention
  • Advancing Construction Claims 2018 Conference Atlanta, GA
  • Pharmaceutical Microbiology UK
  • Cell & Gene Therapy World
  • Immuno-Oncology Frontiers World

  • Latest Jobs
    Sorry, there are currently no entries posted here.